Valley fever (coccidioidomycosis) collaboration and coordination center
Administrative core
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11257661
This center brings together lab scientists and clinicians to coordinate work on Valley fever, including long-term lung problems and meningitis, to speed better tests and treatments for people affected.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11257661 on ClinicalTrials.gov |
What this research studies
As someone affected by Valley fever, this center organizes teams of basic scientists, clinical investigators, and technologists to tackle how the Coccidioides fungus causes disease and how the body responds. The administrative core runs regular data reviews, quarterly meetings, and an annual in-person meeting to align projects and share results. It also supports junior researchers through a mentored Developmental Research Program so new ideas can move forward. The projects linked to the core use lab models, patient samples, and clinical observations to push toward improved diagnostics, therapies, and vaccine leads.
Who could benefit from this research
Good fit: Ideal participants would include people with recent or chronic Valley fever, especially those with lung disease or coccidioidal meningitis, and individuals willing to provide clinical samples or join related clinical projects.
Not a fit: People without Valley fever or with unrelated medical problems are unlikely to gain direct benefit from this administrative center itself.
Why it matters
Potential benefit: If successful, the center could lead to faster diagnosis, better treatments, and information useful for vaccine development against Valley fever.
How similar studies have performed: Previous research has increased understanding of Coccidioides biology and host responses, but effective new treatments and vaccines remain limited, so this coordinated approach builds on established work while pursuing novel directions.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SIL, ANITA — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: SIL, ANITA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases